Real-life lessons on omalizumab and food allergy: The potential for unexplored outcomes
Introduction: IgE-mediated food allergy (FA) represents an increasing global health burden, with rising prevalence and limited therapeutic options beyond allergen avoidance and emergency management. The approval of omalizumab as the first biologic to reduce reactions after accidental food exposure m...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2026-05-01
|
| Edice: | World Allergy Organization Journal |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S1939455126002231 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|